Related Experiment Video

Updated: Aug 25, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K

Novel Biomarkers and Therapeutic Targets for Melanoma

Noa Sabag1, Alexander Yakobson2, Meir Retchkiman1

  • 1Department of Plastic Surgery, Soroka University Medical Center, Ben-Gurion University of the Negev, P.O. Box 151, Beer Sheva 8410100, Israel.

International Journal of Molecular Sciences
|October 14, 2022
PubMed

Insights

Malignant melanoma treatment has advanced significantly with immunotherapy and targeted therapies. Understanding molecular pathways identified key biomarkers, improving options for advanced-stage cancer.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Malignant melanoma is a prevalent global cancer.
  • Early-stage treatment typically involves surgery.
  • Advanced-stage melanoma historically had limited therapeutic options.

Purpose of the Study:

  • To review key biomarkers in malignant melanoma.
  • To discuss the relevance of these biomarkers in current treatment strategies.
  • To highlight the paradigm shift in advanced melanoma therapy.

Main Methods:

  • Literature review of molecular pathways in melanoma.
  • Identification of specific biomarkers.
  • Analysis of biomarker relevance to targeted therapies and immunotherapy.

Main Results:

  • The understanding of molecular pathways has led to the identification of specific biomarkers.
  • These biomarkers are crucial for developing targeted therapies.
  • Immunotherapy and targeted therapies represent a significant advancement in treating advanced melanoma.

Conclusions:

  • Biomarker identification is pivotal for advancing melanoma treatment.
  • Targeted therapies and immunotherapy have transformed the management of advanced melanoma.
  • Continued research into molecular pathways will likely yield further therapeutic innovations.
Keywords:
adjuvant therapyimmunotherapymalignant melanomatargeted therapy

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.9K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

987

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639